Ledger.Open graph →
SEC Form D · filed October 13, 2022

Curavit Clinical Research Corp

Offering
$8.9M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SCARSDALE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Nathanael Lentz · Scarsdale, NYDirectorJoel Morse · Scarsdale, NYExec · DirectorDavid Hanaman · Scarsdale, NYDirectorRich Lester · Scarsdale, NYDirectorJohn D. Haymes · Columbus, OHExec · DirectorJamir Savla · Jersey City, NJDirectorAmar Dedhia · Jersey City, NJDirectorLogan Rutledge · Cedar City, UTDirectorDevang Kantesaria · Miami, FLDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorMichael Kelly · NEW YORK, NYExec · DirectorDrew L. Wellsfry · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗